Skip to main content
Advertisement
Advertisement
OMCL
OMCL logo
Omnicell Inc
39.41
USD
Sponsored
+3.95
+11.14%
Nov 04, 15:59 UTC -5
Closed
exchange

Pre-Market

39.43

+0.02
+0.05%

Omnicell Inc (OMCL) Earnings

OMCL Earnings Reports

Positive Surprise Ratio

OMCL beat 36 of 43 last estimates.

84%

Next Report

Date of Next Report
Feb 03, 2027
Estimate for Q4 26 (Revenue/ EPS)
$307.72M
/
$0.37
Implied change from Q3 26 (Revenue/ EPS)
-0.04%
/
-35.09%
Implied change from Q4 25 (Revenue/ EPS)
-0.70%
/
-7.50%

Omnicell Inc earnings per share and revenue

On Oct 29, 2026, OMCL reported earnings of 0.57 USD per share (EPS) for Q3 26, beating the estimate of 0.42 USD, resulting in a 36.18% surprise. Revenue reached 307.85 million, compared to an expected 310.56 million, with a -0.87% difference. The market reacted with a +2.59% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 0.37 USD, with revenue projected to reach 307.72 million USD, implying an decrease of -35.09% EPS, and decrease of -0.04% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
SOPHiA GENETICS SA Ordinary Shares
Report Date
Nov 03, 2026 For Q3 26
Estimate
-$0.19
Actual
-$0.24
Surprise
-23.84%
logo
American Well Corporation
Report Date
Nov 03, 2026 For Q3 26
Estimate
-$0.76
Actual
-$0.67
Surprise
+12.75%
logo
Pulmonx Corporation Common Stock
Report Date
Oct 27, 2026 For Q3 26
Estimate
-$0.26
Actual
-$0.19
Surprise
+27.40%
logo
Outset Medical, Inc. Common Stock
Report Date
Nov 04, 2026 For Q3 26
Estimate
-$0.71
Actual
-$0.68
Surprise
+4.78%
logo
Tempus AI, Inc. Class A Common Stock
Report Date
Nov 02, 2026 For Q3 26
Estimate
-$0.07
Actual
$0.07
Surprise
+188.05%
logo
Hinge Health, Inc.
Report Date
Nov 02, 2026 For Q3 26
Estimate
$0.60
Actual
$0.71
Surprise
+16.53%
logo
Clover Health Investments, Corp
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.00
Actual
$0.01
Surprise
0.00%
logo
Schrodinger, Inc. Common Stock
Report Date
Nov 04, 2026 For Q3 26
Estimate
-$0.70
Actual
-$0.50
Surprise
+29.57%
logo
Butterfly Network, Inc.
Report Date
Oct 29, 2026 For Q3 26
Estimate
-$0.06
Actual
-$0.05
Surprise
+20.89%
logo
Inspire Medical Systems, Inc.
Report Date
Nov 02, 2026 For Q3 26
Estimate
-$0.22
Actual
$0.14
Surprise
+161.14%
FAQ
For Q3 2026, Omnicell Inc reported EPS of $0.57, beating estimates by 36.18%, and revenue of $307.85M, -0.87% below expectations.
The stock price moved up 2.59%, changed from $35.95 before the earnings release to $36.88 the day after.
The next earning report is scheduled for Feb 03, 2027.
Based on -- analysts, Omnicell Inc is expected to report EPS of $0.37 and revenue of $307.72M for Q4 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement